Trials / Unknown
UnknownNCT06316167
Mandatory Hiatoplasty in Sleeve Gastrectomy for Gastro-Esophageal Reflux Disease
Implementation of Mandatory Hiatoplasty in Sleeve Gastrectomy: Strategy for Gastro-Esophageal Reflux Disease (GERD) Risk Reduction
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 275 (estimated)
- Sponsor
- Instituto Mexicano del Seguro Social · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The goal of this observational study is to learn about incidence of postoperative gastroesophageal reflux disease in mandatory hiatoplasty performed during gastric sleeve surgery. The main question\[s\] it aims to answer are: * Incidence of postoperative GERD in patients undergoing gastric sleeve with mandatory hiatoplasty * Comparison of postoperative complication rates, including GERD Participants will answer a follow-up questionnaire, about postoperative quality of life
Conditions
Timeline
- Start date
- 2024-03-01
- Primary completion
- 2024-07-31
- Completion
- 2024-08-31
- First posted
- 2024-03-18
- Last updated
- 2024-03-18
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT06316167. Inclusion in this directory is not an endorsement.